Author Correction: Genomic characterization of metastatic breast cancers

François Bertucci; Charlotte K Y Ng; Anne Patsouris; Nathalie Droin; Salvatore Piscuoglio; Nadine Carbuccia; Jean Charles Soria; Alicia Tran Dien; Yahia Adnani; Maud Kamal; Séverine Garnier; Guillaume Meurice; Marta Jimenez; Semih Dogan; Benjamin Verret; Max Chaffanet; Thomas Bachelot; Mario Campone; Claudia Lefeuvre; Herve Bonnefoi; Florence Dalenc; Alexandra Jacquet; Maria R De Filippo; Naveen Babbar; Daniel Birnbaum; Thomas Filleron; Christophe Le Tourneau; Fabrice André

doi:10.1038/s41586-019-1380-3

Author Correction: Genomic characterization of metastatic breast cancers

Nature. 2019 Aug;572(7767):E7. doi: 10.1038/s41586-019-1380-3.

Authors

François Bertucci^#¹, Charlotte K Y Ng^#^{2

3

4}, Anne Patsouris^#^{5

6}, Nathalie Droin^{7

8

9}, Salvatore Piscuoglio^{2

3}, Nadine Carbuccia¹⁰, Jean Charles Soria^{11

12}, Alicia Tran Dien¹³, Yahia Adnani¹³, Maud Kamal¹⁴, Séverine Garnier¹⁰, Guillaume Meurice¹³, Marta Jimenez¹⁵, Semih Dogan¹⁶, Benjamin Verret¹⁶, Max Chaffanet¹⁰, Thomas Bachelot¹⁷, Mario Campone^{5

6}, Claudia Lefeuvre¹⁸, Herve Bonnefoi¹⁹, Florence Dalenc²⁰, Alexandra Jacquet¹⁵, Maria R De Filippo², Naveen Babbar²¹, Daniel Birnbaum¹⁰, Thomas Filleron²⁰, Christophe Le Tourneau^{22

23

24}, Fabrice André^{25

26

27}

Affiliations

¹ CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes, Marseille, France. fandre@igr.fr.
² Institute of Pathology, University Hospital Basel, Basel, Switzerland.
³ Clarunis, Department of Biomedicine, University of Basel, Basel, Switzerland.
⁴ Department for BioMedical Research, University of Bern, Bern, Switzerland.
⁵ Inserm, U1232, Nantes, France.
⁶ Institut de Cancérologie de l'Ouest - René Gauducheau, Saint Herblain, France.
⁷ Genomic Core Facility UMS AMMICA Gustave Roussy Cancer Campus, Villejuif, France.
⁸ INSERM, US23, Villejuif, France.
⁹ CNRS, UMS3665, Villejuif, France.
¹⁰ CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes, Marseille, France.
¹¹ Université Paris Sud, Orsay, France.
¹² Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France.
¹³ Bioinformatics Core Facility, Gustave Roussy Cancer Campus, Villejuif, France.
¹⁴ Department of Translational Research, Institut Curie, Saint-Cloud, France.
¹⁵ Unicancer, Paris, France.
¹⁶ Inserm, Gustave Roussy Cancer Campus, UMR981, Villejuif, France.
¹⁷ Centre Léon Bérard, Lyon, France.
¹⁸ Centre Eugène Marquis, Rennes, France.
¹⁹ Institut Bergonié, Bordeaux, France.
²⁰ Institut Claudius-Regaud, IUCT-oncopôle, Toulouse, France.
²¹ Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
²² Department of Drug Development and Innovation, Institut Curie, Saint-Cloud, France.
²³ INSERM U900, Saint-Cloud, France.
²⁴ Versailles Saint Quentin en Yvelines University, Montigny le Bretonneux, France.
²⁵ Université Paris Sud, Orsay, France. fandre@igr.fr.
²⁶ Inserm, Gustave Roussy Cancer Campus, UMR981, Villejuif, France. fandre@igr.fr.
²⁷ Department of Medical Oncology, Gustave Roussy, Villejuif, France. fandre@igr.fr.

^# Contributed equally.

PMID: 31308536
DOI: 10.1038/s41586-019-1380-3

Abstract

An Amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Published Erratum